no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Connectomics: A new paradigm for understanding brain disease
|
Fornito, Alex |
|
2015 |
25 |
5 |
p. 733-748 16 p. |
article |
2 |
Contents
|
|
|
2015 |
25 |
5 |
p. OBC- 1 p. |
article |
3 |
Developments in the field of antidepressants, where do we go now?
|
Artigas, Francesc |
|
2015 |
25 |
5 |
p. 657-670 14 p. |
article |
4 |
ECNP Calendar of Events
|
|
|
2015 |
25 |
5 |
p. I- 1 p. |
article |
5 |
Editorial Board
|
|
|
2015 |
25 |
5 |
p. IFC- 1 p. |
article |
6 |
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
|
Szyf, Moshe |
|
2015 |
25 |
5 |
p. 682-702 21 p. |
article |
7 |
How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
|
Kempton, Matthew J. |
|
2015 |
25 |
5 |
p. 725-732 8 p. |
article |
8 |
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
|
Millan, Mark J. |
|
2015 |
25 |
5 |
p. 599-656 58 p. |
article |
9 |
Present and future of developmental neuropsychopharmacology
|
Arango, Celso |
|
2015 |
25 |
5 |
p. 703-712 10 p. |
article |
10 |
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
|
Bayer, Thomas A. |
|
2015 |
25 |
5 |
p. 713-724 12 p. |
article |
11 |
The current and potential impact of genetics and genomics on neuropsychopharmacology
|
Harrison, Paul J. |
|
2015 |
25 |
5 |
p. 671-681 11 p. |
article |
12 |
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress
|
Millan, Mark J. |
|
2015 |
25 |
5 |
p. 591-598 8 p. |
article |